Table 1.
Clinical outcomes for hepatocellular carcinoma patients accompanying portal vein tumor thrombosis following surgical resection
| Ref. | PVTT status1 | No. of patients |
Survival2 |
||
| Median (mo) | 1-yr (%) | 3-yr (%) | |||
| Shi et al[49] | Vp2 | 139 | NR | 52.1 | 25.1 |
| Vp3 | 169 | 38.2 | 17.78 | ||
| Vp4 | 78 | 24.7 | 3.6 | ||
| Beyond Vp4 | 20 | 18.3 | 0 | ||
| Lin et al[50] | Vp2 | ||||
| Vp3 | 63 | NR | 52.1 | 16 | |
| Vp4 | 5 | 33.1 | 0 | ||
| Chen et al[78] | Vp2-4 | 88 | 9 | 31.1 | 15.2 |
| Matono et al[79] | Vp3-4 | 29 | 16.9 | 62.1 | 24.1 |
1
Beyond Vp4 = extending to superior mesenteric vein;
2
Intrahepatic recurred lesions were treated by percutaneous ethanol injection therapy, radiofrequency ablation, transarterial chemoembolization, or systemic chemotherapy based on their hepatic functional reserve and the pattern of intrahepatic recurrence. NR: Not reported; PVTT: Portal vein tumor thrombosis.